All News
Filter News
Found 808,606 articles
-
Agilent Introduces Breakthrough Flow Cytometer
6/24/2019
Agilent Technologies Inc. (NYSE: A) today introduced its first new product from recently acquired ACEA Biosciences, at the 34th Congress of the International Society for Advancement of Cytometry, CYTO 2019 Congress, being held June 22–26, 2019 in Vancouver, Canada
-
Sensyne Health, Evotec, OSI and the University of Oxford create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
6/24/2019
LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at the University of Oxford
-
Detroit Tigers Pink Out the Park Friday, July 19, continues eight year tradition, bringing Fans and Community Together to Raise Awareness of Breast Health
6/24/2019
The Detroit Tigers will continue its tradition of uniting our community to encourage breast health awareness at the eighth annual Pink Out the Park on Friday, July 19, when the Tigers face the Toronto Blue Jays at Comerica Park.
-
Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option to Purchase Additional Shares
6/24/2019
The Company intends to use the net proceeds of the Offering to accelerate and expand the global development of ZW25 both as a single agent and in combination with other anti-cancer agents in a variety of HER2-expressing tumors
-
NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patients With Solid Tumors
6/24/2019
NantKwest Inc. (Nasdaq:NK), today announced that the company’s PD-L1 t-haNK investigational new drug application (IND) has cleared FDA review and the program has now transitioned to a first-in-human clinical trial in patients with locally advanced or metastatic solid cancers
-
Early Studies Show EBTATE is Well Tolerated and Effective in Treating Neuroendocrine Tumors
6/24/2019
Talk entitled “Safety and Response of an Evans Blue-modified 177Lu-labeled Octreotate (EBTATE) in Treatment of Metastatic Neuroendocrine Tumors: A Pilot Prospective Study” at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Anaheim this June*.
-
Bristol-Myers Squibb Provides Update on Pending Merger with Celgene
6/24/2019
Bristol-Myers Squibb Company provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation.
-
Study Shows Seizure Freedom for Most Epilepsy Patients with Minimally Invasive Laser Ablation Procedure
6/24/2019
Performed minimally invasive laser ablation on 234 epilepsy patients and found that the majority were seizure-free, according to a recently published study.
-
Novanta Signs Agreement to Acquire ARGES
6/24/2019
Combined capabilities will provide intelligent subsystems for demanding laser-based applications
-
Prometheus Research and HealthVerity Announce Selection by Epilepsy Foundation to Develop a Community Data Resource
6/24/2019
Epilepsy Foundation, the largest national epilepsy advocacy organization, has selected the team of Prometheus Research and HealthVerity to develop a new data infrastructure capable of creating the largest hub of repurposable data on epilepsy in the world.
-
Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer
6/24/2019
Industry Veteran to Take the Helm of Next-Generation Oncology Company Focused on Harnessing Human Immune Response
-
Alnylam Presents New ONPATTRO® (patisiran) Results at the 2019 Peripheral Nerve Society Annual Meeting
6/24/2019
Patisiran Global Open-Label Extension (OLE) Study Demonstrates Maintained Reversal of Disease Progression and Consistent Safety Profile, with Greater Than Four Years of Patient Experience and Over 6,000 Doses Administered
-
Craneware Showcases Use of Artificial Intelligence (AI) to Improve Financial Performance at HFMA Annual Conference 2019
6/24/2019
Craneware (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today announced it will be joining Moffitt Cancer Center at the HFMA Annual Conference 2019 to discuss how the organizations are partnering to gain an understanding of AI, and its application to charge capture and denials management
-
Global Thoracic Surgery Market to Grow by USD 12.93 Billion during 2019-2023 | Technavio
6/24/2019
Technavio’s latest market research report on the global thoracic surgery market predicts the market to witness a CAGR of over 9% during the forecast period.
-
MolecularMatch appoints Eric Pulaski as President
6/24/2019
Pulaski joins executive team to drive product strategy and revenue growth
-
Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent
6/24/2019
Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA)
-
Cadwell Launches Arc Apollo EEG
6/24/2019
Apollo is FDA cleared and CE marked and is released for sale in the United States, Canada and the European Union
-
Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma
6/24/2019
Bristol-Myers Squibb Company announced topline results from CheckMate -459, a randomized Phase 3 study evaluating Opdivo versus sorafenib as a first-line treatment in patients with unresectable hepatocellular carcinoma.
-
Phreesia Files Registration Statement for Initial Public Offering
6/24/2019
Phreesia announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering of shares of its common stock.
-
Phitonex Launches NovaFluor Dyes Enabling High Resolution Biology for Single Cell Analysis
6/24/2019
New Dyes and Platform Provide a Transformative Leap in Fluorescence by Design to Enable Research